News

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
By increasing muscle loss and decreasing cardiorespiratory fitness, weight-loss drugs can negatively affect mortality risk, ...
New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.
Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...
A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.